An analysis of fear inhibition and fear extinction in a sample of veterans with obstructive sleep apnea (OSA): Implications for co-morbidity with post-traumatic stress disorder (PTSD).


Journal

Behavioural brain research
ISSN: 1872-7549
Titre abrégé: Behav Brain Res
Pays: Netherlands
ID NLM: 8004872

Informations de publication

Date de publication:
23 04 2021
Historique:
received: 03 07 2020
revised: 13 01 2021
accepted: 04 02 2021
pubmed: 13 2 2021
medline: 21 1 2022
entrez: 12 2 2021
Statut: ppublish

Résumé

Obstructive sleep apnea (OSA) is a respiratory condition characterized by interrupted sleep due to repeated, temporary collapse of the soft tissue of the upper airway that can lead to a cascade of physiological and psychological adverse health outcomes. The most common therapeutic interventions for OSA patients include the application of continuous positive airway pressure (CPAP) which acts to keep the airway open and, as such, provides less interrupted and more restorative sleep. Improved sleep has been linked to more efficacious treatments for psychiatric conditions most notably those that include cognitive-behavioral elements, new learning, and memory consolidation. In the current study, we investigated the acquisition, inhibition, and extinction of conditioned fear in OSA patients, before and after CPAP therapy, using an established fear-potentiated startle paradigm. Patients with OSA displayed an intact ability to acquire, inhibit, and extinguish fear prior to CPAP treatment and this ability was significantly enhanced following CPAP usage. In addition, those patients with more severe OSA, as measured by apnea-hypopnea index (AHI), were more likely to show improved fear inhibition and extinction. Lastly, we observed impairments in discrimination between reinforced and nonreinforced conditioned stimuli, in the inhibition of fear, and in fear extinction in a subset of patients with OSA and co-morbid posttraumatic stress disorder (PTSD). These data suggest that evolving treatment algorithms for PTSD should address disrupted sleep problems prior to initiation of inhibition/extinction-based exposure therapies.

Identifiants

pubmed: 33577879
pii: S0166-4328(21)00059-0
doi: 10.1016/j.bbr.2021.113172
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

113172

Informations de copyright

Copyright © 2021 Elsevier B.V. All rights reserved.

Auteurs

Christopher Reist (C)

Research Service, Long Beach VA Healthcare System, 5901 East 7(th) Street, Long Beach, CA, 90822, United States; Science 37, 12121 Bluff Creek Drive, Los Angeles, CA, 90094, United States.

Tanja Jovanovic (T)

Neuroscience Center for Anxiety, Stress, and Trauma (NeuroCAST), Department of Psychiatry and Behavioral Neurosciences, Wayne State University School of Medicine, 3901 Chrysler Service Drive, Detroit, MI, 48201, United States.

Diana Kantarovich (D)

Chicago Medical School, Rosalind Franklin University, 3333 Green Bay Road, North Chicago, IL, 60064, United States.

Leah Weingast (L)

Teachers College, Columbia University, 525 West 120(th) Street, New York, NY, 10027, United States.

Michael Hollifield (M)

Research Service, Long Beach VA Healthcare System, 5901 East 7(th) Street, Long Beach, CA, 90822, United States.

Mahmood Novin (M)

Research Service, Long Beach VA Healthcare System, 5901 East 7(th) Street, Long Beach, CA, 90822, United States.

Sakineh Khalaghizadeh (S)

Research Service, Long Beach VA Healthcare System, 5901 East 7(th) Street, Long Beach, CA, 90822, United States.

Behrouz Jafari (B)

Research Service, Long Beach VA Healthcare System, 5901 East 7(th) Street, Long Beach, CA, 90822, United States.

Renie George (R)

Neuroscience Center for Anxiety, Stress, and Trauma (NeuroCAST), Department of Psychiatry and Behavioral Neurosciences, Wayne State University School of Medicine, 3901 Chrysler Service Drive, Detroit, MI, 48201, United States.

Manessa Riser (M)

Neuroscience Center for Anxiety, Stress, and Trauma (NeuroCAST), Department of Psychiatry and Behavioral Neurosciences, Wayne State University School of Medicine, 3901 Chrysler Service Drive, Detroit, MI, 48201, United States.

Jessica Woodford (J)

Neuroscience Center for Anxiety, Stress, and Trauma (NeuroCAST), Department of Psychiatry and Behavioral Neurosciences, Wayne State University School of Medicine, 3901 Chrysler Service Drive, Detroit, MI, 48201, United States.

Seth D Norrholm (SD)

Neuroscience Center for Anxiety, Stress, and Trauma (NeuroCAST), Department of Psychiatry and Behavioral Neurosciences, Wayne State University School of Medicine, 3901 Chrysler Service Drive, Detroit, MI, 48201, United States. Electronic address: snorrholm@wayne.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH